The global
lung cancer surgery market is set to witness a growth rate of
4% in the next 5 years. Increasing incidence of lung
cancer; advancements in surgical techniques, growing geriatric population;
growing focus on early cancer detection and treatment; favorable reimbursement
policies and integration of advanced imaging and diagnostic tools are some of
the key factors driving the lung cancer surgery market.
Lung cancer surgery is a medical procedure aimed at removing
cancerous tissue from the lungs. It is primarily used to treat early-stage lung
cancer, particularly non-small cell lung cancer (NSCLC), and involves various
techniques such as lobectomy (removal of a lung lobe), pneumonectomy (removal
of an entire lung), and segmentectomy (removal of part of a lobe). Advanced
methods like video-assisted thoracoscopic surgery, and robotic-assisted
thoracic surgery offer minimally invasive options, reducing recovery time and
complications. Lung cancer surgery is often combined with other treatments,
including chemotherapy, radiation, or immunotherapy, to improve patient
outcomes and reduce recurrence.
Unlock key findings! Fill out a quick inquiry to access a
sample report
https://meditechinsights.com/lung-cancer-surgery-market/request-sample/
Increasing incidence of lung cancer to propel market
demand
The increasing incidence of lung cancer indirectly drives
the medical aesthetics market by fueling demand for aesthetic
procedures to manage physical changes resulting from cancer treatments.
According to the International Agency for Research (IARC), Lung cancer was the
most frequently diagnosed cancer in 2022, responsible for almost 2.5
million new cases, or 12.4% of all cancers globally.
Lung cancer therapies, such as chemotherapy and radiation, often lead to hair
loss, skin changes, and facial volume loss, prompting patients to seek cosmetic
solutions for improved appearance and self-confidence. Additionally,
advancements in minimally invasive aesthetic procedures, like dermal fillers
and laser therapies, provide non-surgical options for cancer survivors. The
growing focus on post-cancer care and the rising awareness of aesthetic
treatments contribute to the expansion of the medical aesthetics market.
Advancements in surgical techniques are driving the
market growth
Advancements in surgical techniques are significantly
driving the lung cancer surgery market by improving precision, reducing
complications, and enhancing patient outcomes. Minimally invasive procedures
like video-assisted thoracoscopic surgery and robotic-assisted thoracic surgery
enable smaller incisions, faster recovery times, and lower post-operative risks
compared to traditional open surgeries. Enhanced imaging technologies,
real-time navigation systems, and robotic platforms improve tumor localization
and surgical accuracy, leading to better survival rates. Additionally, the
adoption of personalized surgical approaches, based on genetic profiling and
AI-driven decision-making, is further optimizing treatment, making surgery a
preferred option for early-stage lung cancer patients.
Competitive Landscape Analysis
The global lung cancer surgery market is marked by the
presence of established and emerging market players such as Intuitive
Surgical, Medtronic, Johnson & Johnson, Olympus Corporation, Siemens
Healthineers, Teleflex Incorporated, Accuray Incorporated, AngioDynamics,
KARL STORZ SE & Co. KG, and Richard Wolf
GmbH; among others. Some of the key strategies adopted by market
players include new product development, strategic partnerships and
collaborations, and geographic expansion.
Get exclusive insights - download your sample report
today
https://meditechinsights.com/lung-cancer-surgery-market/request-sample/
Global Lung Cancer Surgery Market Segmentation
This report by Medi-Tech Insights provides the size of
the global lung cancer surgery market at the regional- and country-level
from 2023 to 2030. The report further segments the market based on product,
application, end user.
Market Size & Forecast (2023-2030), By Product, USD
Million
- Surgical
Instruments
- Powered
Surgical Instruments
- Hand
Instruments
- Monitoring
and Visualizing Systems
- Cameras
and Video Support
- Endoscopic
Trocars with Optical Views
- Endo
surgical Equipment
- Others
Market Size & Forecast (2023-2030), By Application,
USD Million
- Thoracotomy
- Lobectomy
- Sleeve
Resection
- Segmentectomy
- Pneumonectomy
- Minimally
Invasive Surgeries
Market Size & Forecast (2023-2030), By End User, USD
Million
- Hospitals
- Ambulatory
Surgical Centers (ASCs)
- Others
Market Size & Forecast (2023-2030), By Region, USD
Million
- North
America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest
of Europe
- Asia
Pacific
- China
- India
- Japan
- Rest
of Asia Pacific
- Latin
America
- Middle
East & Africa
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research
& insights firm. Our clients include Fortune 500 companies, blue-chip
investors & hyper-growth start-ups. We have completed 100+ projects in
Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research combined
with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply
side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
Comments
Post a Comment